MERIT MEDICAL SYSTEMS INC Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax
MERIT MEDICAL SYSTEMS INC (MMSI) reported Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax of $2.10 million for the 12-month period ending 2018-12-31, per its 10-K filed 2021-03-01.
Discontinued › Income Statement › Other Income
us-gaap:OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodBeforeTax · last filed 2021-03-01
- MERIT MEDICAL SYSTEMS INC other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2018-12-31 was -$1.44M, a 222.50% decline year-over-year.
- MERIT MEDICAL SYSTEMS INC other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2018-09-30 was $667.00K.
- MERIT MEDICAL SYSTEMS INC other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2018-06-30 was $881.00K.
- MERIT MEDICAL SYSTEMS INC other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for the quarter ending 2018-03-31 was $1.99M, a 137.99% increase year-over-year.
- MERIT MEDICAL SYSTEMS INC other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2018 was $2.10M, a 56.10% increase from fiscal 2017.
- MERIT MEDICAL SYSTEMS INC other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2017 was $1.34M, a 71.91% decline from fiscal 2016.
- MERIT MEDICAL SYSTEMS INC other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2016 was $4.78M.
- MERIT MEDICAL SYSTEMS INC other comprehensive income (loss), unrealized gain (loss) on derivatives arising during period, before tax for fiscal 2015 was -$571.00K.
| Period end | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 3 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 6 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 9 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 12 month | Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2018-12-31 | -$1.44M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | -$776.00K derived: sum of 2 quarters · filed 2021-03-01 | $105.00K derived: sum of 3 quarters · filed 2021-03-01 | $2.10M 10-K · filed 2021-03-01 | |
| 2018-09-30 | $667.00K 10-Q · filed 2018-11-09 | $1.55M derived: sum of 2 quarters · filed 2018-11-09 | $3.54M 10-Q · filed 2018-11-09 | $4.72M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $881.00K 10-Q · filed 2018-08-09 | $2.87M 10-Q · filed 2018-08-09 | $4.05M derived: sum of 3 quarters · filed 2020-03-02 | $3.91M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-03-31 | $1.99M 10-Q · filed 2018-05-10 | $3.17M derived: sum of 2 quarters · filed 2020-03-02 | $3.03M derived: sum of 3 quarters · filed 2020-03-02 | $2.50M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2017-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $1.03M derived: sum of 2 quarters · filed 2020-03-02 | $507.00K derived: sum of 3 quarters · filed 2020-03-02 | $1.34M 10-K · filed 2020-03-02 | $901.00K 10-K · filed 2018-03-01 |
| 2017-09-30 | -$144.00K 10-Q · filed 2018-11-09 | -$671.00K derived: sum of 2 quarters · filed 2018-11-09 | $166.00K 10-Q · filed 2018-11-09 | $5.93M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-06-30 | -$527.00K 10-Q · filed 2018-08-09 | $310.00K 10-Q · filed 2018-08-09 | $6.08M derived: sum of 3 quarters · filed 2019-03-01 | $5.97M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2017-03-31 | $837.00K 10-Q · filed 2018-05-10 | $6.61M derived: sum of 2 quarters · filed 2019-03-01 | $6.50M derived: sum of 3 quarters · filed 2019-03-01 | $6.35M derived: sum of 4 quarters · filed 2019-03-01 | |
| 2016-12-31 | $5.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $5.67M derived: sum of 2 quarters · filed 2019-03-01 | $5.51M derived: sum of 3 quarters · filed 2019-03-01 | $4.78M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$103.00K 10-Q · filed 2017-11-09 | -$255.00K derived: sum of 2 quarters · filed 2017-11-09 | -$984.00K 10-Q · filed 2017-11-09 | -$134.00K derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-06-30 | -$152.00K 10-Q · filed 2017-08-07 | -$881.00K 10-Q · filed 2017-08-07 | -$31.00K derived: sum of 3 quarters · filed 2018-03-01 | -$652.00K derived: sum of 4 quarters · filed 2018-03-01 | |
| 2016-03-31 | -$729.00K 10-Q · filed 2017-05-10 | $121.00K derived: sum of 2 quarters · filed 2018-03-01 | -$500.00K derived: sum of 3 quarters · filed 2018-03-01 | -$402.00K derived: sum of 4 quarters · filed 2018-03-01 | |
| 2015-12-31 | $850.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | $229.00K derived: sum of 2 quarters · filed 2018-03-01 | $327.00K derived: sum of 3 quarters · filed 2018-03-01 | -$571.00K 10-K · filed 2018-03-01 | |
| 2015-09-30 | -$621.00K 10-Q · filed 2016-11-09 | -$523.00K derived: sum of 2 quarters · filed 2016-11-09 | -$1.42M 10-Q · filed 2016-11-09 | -$1.99M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-06-30 | $98.00K 10-Q · filed 2016-08-08 | -$800.00K 10-Q · filed 2016-08-08 | -$1.36M derived: sum of 3 quarters · filed 2017-03-01 | -$570.00K derived: sum of 4 quarters · filed 2017-03-01 | |
| 2015-03-31 | -$898.00K 10-Q · filed 2016-05-09 | -$1.46M derived: sum of 2 quarters · filed 2017-03-01 | -$668.00K derived: sum of 3 quarters · filed 2017-03-01 | -$1.45M derived: sum of 4 quarters · filed 2017-03-01 | |
| 2014-12-31 | -$564.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $230.00K derived: sum of 2 quarters · filed 2017-03-01 | -$552.00K derived: sum of 3 quarters · filed 2017-03-01 | -$630.00K 10-K · filed 2017-03-01 | |
| 2014-09-30 | $794.00K 10-Q · filed 2015-11-09 | $12.00K derived: sum of 2 quarters · filed 2015-11-09 | -$66.00K 10-Q · filed 2015-11-09 | $394.00K derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-06-30 | -$782.00K 10-Q · filed 2015-08-07 | -$860.00K 10-Q · filed 2015-08-07 | -$400.00K derived: sum of 3 quarters · filed 2016-02-29 | -$1.12M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2014-03-31 | -$77.00K 10-Q · filed 2015-05-11 | $382.00K derived: sum of 2 quarters · filed 2016-02-29 | -$340.00K derived: sum of 3 quarters · filed 2016-02-29 | $2.55M derived: sum of 4 quarters · filed 2016-02-29 | |
| 2013-12-31 | $459.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$263.00K derived: sum of 2 quarters · filed 2016-02-29 | $2.62M derived: sum of 3 quarters · filed 2016-02-29 | $2.99M 10-K · filed 2016-02-29 | |
| 2013-09-30 | -$722.00K 10-Q · filed 2014-11-10 | $2.16M derived: sum of 2 quarters · filed 2014-11-10 | $2.53M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $2.89M 10-Q · filed 2014-08-11 | $3.25M 10-Q · filed 2014-08-11 | |||
| 2012-12-31 | -$1.79M 10-K · filed 2015-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |